The New York Times alleges OpenAI concealed evidence in an ongoing copyright infringement lawsuit, while the company simultaneously loses its No. 2 executive and discontinues ChatGPT Atlas. For healthcare AI implementations, this signals potential instability in a vendor many organizations rely on for clinical documentation and workflow automation. Legal exposure around training data sourcing raises questions about compliance risk for health systems deploying OpenAI models in regulated environments. Leadership departures typically precede strategic pivots that could affect API stability and feature roadmaps healthcare organizations have integrated into production systems.